Innovator Equity Dual Directional 10 Buffer ETF - November (DDTN) seeks to provide exposure to the SPDR S&P 500 ETF Trust with a 10% downside buffer and capped upside over a one-year outcome period ending in November. This defined outcome ETF uses options strategies to protect against the first 10% of losses while limiting gains to a predetermined cap.

How It Works

DDTN employs a sophisticated options overlay strategy using FLEX options on the S&P 500 to create its buffer and cap structure. The fund purchases put spreads to provide downside protection and sells call spreads to finance the buffer while capping upside participation. The outcome period resets annually in November, with new buffer and cap levels established. Holdings consist primarily of options contracts and short-term Treasury securities as collateral, with positions actively managed throughout the outcome period.

Key Features

  • Provides 10% downside buffer protection, absorbing first 10% of S&P 500 losses over the November-to-November outcome period
  • Dual directional exposure allows participation in both upward and downward S&P 500 movements within defined parameters
  • Annual reset in November establishes new buffer and cap levels based on prevailing market conditions and option pricing

Risks

  • This ETF can lose value beyond the 10% buffer if S&P 500 declines exceed the protection threshold, with losses magnified thereafter
  • Upside participation is capped at a predetermined level, potentially missing significant market gains during strong bull markets exceeding the cap
  • Options complexity and time decay can cause tracking errors, especially when held outside the intended November-to-November outcome period

Who Should Own This

Best suited for conservative investors with medium risk tolerance seeking downside protection over a one-year time horizon. Appropriate as a satellite holding (5-15% allocation) for investors wanting S&P 500 exposure with defined risk parameters. Requires understanding of options mechanics and commitment to the November outcome period for optimal results.